Status:
UNKNOWN
Effectiveness of Intratympanic Dexamethasone With Ligmocaine for Alleviation of Tinnitus
Lead Sponsor:
Combined Military Hospital, Pakistan
Conditions:
Tinnitus
Eligibility:
All Genders
19-75 years
Phase:
PHASE4
Brief Summary
Objective: To determine the effectiveness of Intratympanic dexamethasone with lignocaine in control of idiopathic tinnitus. Methodology: 264 consenting patients with idiopathic unilateral tinnitus pr...
Eligibility Criteria
Inclusion
- score 20 or above on modified tinnitus handicap inventory
Exclusion
- head trauma, tympanic membrane perforation, depression, ear surgery
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT04798391
Start Date
March 1 2021
End Date
May 1 2021
Last Update
March 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Combined Military Hospital
Quetta, Balochistan, Pakistan, 1234